Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde regimen in metastatic pancreatic adenocarcinoma
Phase III NAPOLI 3 trial is the largest and has the longest…
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33…
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused…
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence…
MinIO AIStor Sets New Standard for AI and Data-Intensive Workloads with Industry-First AWS S3 Express API Support
Enterprise object storage with built-in replication brings S3 Express API performance to…
Data Speaks Officially Launches to Redefine Marketing Measurement for the Digital Era
PORTLAND, OR, May 30, 2025 (GLOBE NEWSWIRE) -- After a year of…
Altair Named a Leader in the June 2025 Gartner Magic Quadrant for Data Science and Machine Learning Platforms for Second Consecutive Year
Altair recognized for Completeness of Vision and Ability to Execute TROY, Mich.,…